Royston, United Kingdom

David Evans

USPTO Granted Patents = 16 


 

Average Co-Inventor Count = 4.3

ph-index = 5

Forward Citations = 50(Granted Patents)


Location History:

  • Ealing, GB (2008)
  • Bushey, GB (2010 - 2013)
  • London, GB (2009 - 2016)
  • Royston, GB (2017 - 2022)

Company Filing History:


Years Active: 2008-2022

Loading Chart...
Loading Chart...
Loading Chart...
16 patents (USPTO):

Title: The Innovative Contributions of David Evans

Introduction

David Evans is a notable inventor based in Royston, GB, recognized for his significant contributions to the field of pharmaceuticals. With a total of 16 patents to his name, Evans has made strides in developing compounds that have potential therapeutic applications.

Latest Patents

Among his latest patents are the "Substituted imidazo[4,5-c]pyridine compounds and compositions thereof," which include a compound of formula (I) or a pharmaceutically acceptable salt, or N-oxide thereof, that serves as an inhibitor of SSAO activity. Another notable patent is for "Imidazo[4,5-c]pyridine and pyrrolo[2,3-c]pyridine derivatives as SSAO inhibitors," which details a process for preparing a compound of formula (Ia) or a pharmaceutically acceptable salt, or N-oxide thereof, through specific chemical reactions.

Career Highlights

Throughout his career, David Evans has worked with several companies, including Proximagen Limited and Cadlink Technology Corporation. His work in these organizations has contributed to advancements in drug development and innovative pharmaceutical solutions.

Collaborations

Evans has collaborated with notable colleagues such as Iain Simpson and Edward Savory, enhancing the collaborative efforts in his research and development projects.

Conclusion

David Evans stands out as a prominent inventor whose work in pharmaceutical compounds has the potential to impact the industry significantly. His innovative spirit and dedication to research continue to drive advancements in the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…